Status:
ACTIVE_NOT_RECRUITING
Coronary CT Angiogram - Prognostic Value of Adverse Plaque Features in Guiding Treatment (CT-PLAQUE)
Lead Sponsor:
The University of Hong Kong
Conditions:
Determining if the Presence of Adverse Plaque Features Identified From the CT Angiogram Can Help Determining Prognosis and Guide Treatment Options
Eligibility:
All Genders
18-99 years
Brief Summary
The study aims at determining if the presence of adverse plaque features identified from the CT angiogram can help determine prognosis and guide treatment options.
Eligibility Criteria
Inclusion
- Patient who is ≥ 18 years old presented with chest pain and has undergone CTA between 01-Jan-2012 and 31-Dec-2022 before treatment
- If multiple CTAs are taken, the most updated one before treatment commencement will be chosen.
Exclusion
- Patient who did not undergo cardiac CT scan due to inability to undergo cardiac CT scanning, kidney failure (serum creatinine \>250 μmol/L or estimated glomerular filtration rate \<30 mL/min), major allergy to contrast.
Key Trial Info
Start Date :
January 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
22000 Patients enrolled
Trial Details
Trial ID
NCT07212751
Start Date
January 29 2020
End Date
December 31 2027
Last Update
October 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Hong Kong
Hong Kong, Hong Kong